Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started 

  • (+01) 512 835 8026
  • Email Us
Get a Quote Contact | FAQ's | Blog
Rules-Based Medicine Rules-Based Medicine

a Q<sup>2</sup> Solutions Company

Toggle menu

Skip to content
  • About Us
    • About RBM

      Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.
    • About RBM

      • About Us
      • Our Scientists
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications
    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog
    • Data Quality

      • Overview
      • RBM Technology
  • Biomarker Solutions
    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • NEW! Idiopathic Pulmonary Fibrosis (IPF) Biomarkers
      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support
    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools
    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order
    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions
    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist
    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

Category Archives: Neuroscience and Neurological

20 Jul 2013

Evidence Supporting another Amyloid Biomarker of Alzheimer’s

July 20, 2013
Rules-Based Medicine
Blog, Neuroscience and Neurological
Researchers at the UC Davis Alzheimer's Disease Center have identified the protein amylin as another possible biomarker of AD. Amylin is a protein tha...
Read More
21 Mar 2013

Metabolic Biomarker Associated with Migraine Severity

March 21, 2013
Rules-Based Medicine
Blog, Neuroscience and Neurological
Migraines, severe headaches that last for greater than four hours, are often characterized by specific symptoms such as nausea, sensitivity to light a...
Read More
4 Mar 2013

Blood-Based Biomarkers Included in Scientific American Timeline of Schizophrenia Research

March 4, 2013
Rules-Based Medicine
Blog, Neuroscience and Neurological, Utilized Rules-Based Medicine's Services
Less than two hundred years ago schizophrenia emerged from a tangle of mental disorders known simply as madness. Today its diagnosis remains shrouded...
Read More
14 Jan 2013

Levels of an Inflammatory Marker Linked to Depression

January 14, 2013
Rules-Based Medicine
Blog, Inflammation, Neuroscience and Neurological
There is mounting evidence that systemic inflammation is involved in depression and now a recent article in JAMA Psychiatry supports this hypothesis....
Read More
28 Sep 2012

More Research Supporting Biomarker for Parkinson’s Disease

September 28, 2012
Rules-Based Medicine
Blog, Neuroscience and Neurological
A new study published in the journal Nature Communications, uncovers the role of alpha-synuclein in the non-familial form of Parkinson's. Extra copies...
Read More
11 Sep 2012

A Biomarker for Patient Stratification in a Clinically Depressed Population

September 11, 2012
Rules-Based Medicine
Blog, Inflammation, Neuroscience and Neurological
Clinical depression can be a difficult disease to treat since there is no perfect way to select which antidepressant will be best for the patient. Oft...
Read More
8 Aug 2012

Blood-based Biomarker for Amyotrophic Lateral Sclerosis (ALS) Discovered

August 8, 2012
Rules-Based Medicine
Blog, Inflammation, Neuroscience and Neurological
Researchers at Harvard Medical School and the Tufts School of Medicine have identified an inflammatory response that is associated with ALS. Using a m...
Read More
1 2 3 4 5

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Rules-Based Medicine's Services (43)

ABOUT RBM

Overview
Our Scientists
Quality Policy
Employment
Partners
Sales Team
Certifications

A Q2 Solutions Company

Contact Us

Q2 Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2023 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information